Cadrenal Therapeutics, Inc.
CVKD
$12.32
-$0.1618-1.30%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -126.20% | -164.78% | -27.45% | 40.71% | 51.36% |
| Total Depreciation and Amortization | 191.30% | 183.33% | -5.00% | -8.70% | 4.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | 260.27% | 207.58% | -69.60% | -91.87% | -93.68% |
| Change in Net Operating Assets | -75.40% | 180.51% | 1,198.20% | 182.64% | 2,131.03% |
| Cash from Operations | -148.87% | -157.21% | -108.41% | -93.51% | -54.94% |
| Capital Expenditure | -- | -196.97% | -96.97% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -196.97% | -96.97% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 30.97% | 10.62% | -57.72% | -87.44% | 14.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 87.98% | 68.58% | -24.56% | -87.63% | 4.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.48% | -69.68% | -80.70% | -152.67% | -43.04% |